VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $613,000 | +130.5% | 24,969 | +89.0% | 0.01% | +125.0% |
| Q2 2016 | $266,000 | -87.0% | 13,211 | -34.6% | 0.00% | -83.3% |
| Q4 2015 | $2,053,000 | +385.3% | 20,200 | +751.6% | 0.02% | +300.0% |
| Q3 2015 | $423,000 | +41.0% | 2,372 | +75.4% | 0.01% | +50.0% |
| Q2 2015 | $300,000 | -99.4% | 1,352 | -99.6% | 0.00% | -99.5% |
| Q3 2014 | $46,628,000 | -33.7% | 355,400 | -36.3% | 0.77% | -34.2% |
| Q2 2014 | $70,375,000 | +6416.2% | 558,000 | +5965.2% | 1.17% | +5236.4% |
| Q4 2013 | $1,080,000 | – | 9,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |